Sponsor Pipeline

Chang Yingjun Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07451236 CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA Transplantation Candidates With Hematological Diseases Not Yet Recruiting
Get alerts when Chang Yingjun's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free